- Home
- GNTA vs FORA Comparison
GNTA vs FORA Comparison
Compare GNTA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- FORA
- Stock Information
- Founded
- GNTA 2014
- FORA 2014
- Country
- GNTA Italy
- FORA United States
- Employees
- GNTA N/A
- FORA 37
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- FORA Computer Software: Prepackaged Software
- Sector
- GNTA Health Care
- FORA Technology
- Exchange
- GNTA Nasdaq
- FORA Nasdaq
- Market Cap
- GNTA 62.9M
- FORA 69.4M
- IPO Year
- GNTA 2021
- FORA N/A
- Fundamental
- Price
- GNTA $3.10
- FORA $2.27
- Analyst Decision
- GNTA Strong Buy
- FORA Strong Buy
- Analyst Count
- GNTA 1
- FORA 1
- Target Price
- GNTA $25.00
- FORA $5.00
- AVG Volume (30 Days)
- GNTA 16.3K
- FORA 75.0K
- Earning Date
- GNTA 01-01-0001
- FORA 11-12-2025
- Dividend Yield
- GNTA N/A
- FORA N/A
- EPS Growth
- GNTA N/A
- FORA N/A
- EPS
- GNTA N/A
- FORA N/A
- Revenue
- GNTA N/A
- FORA $25,031,040.00
- Revenue This Year
- GNTA N/A
- FORA $47.82
- Revenue Next Year
- GNTA N/A
- FORA $10.11
- P/E Ratio
- GNTA N/A
- FORA N/A
- Revenue Growth
- GNTA N/A
- FORA 18.59
- 52 Week Low
- GNTA $2.56
- FORA $1.64
- 52 Week High
- GNTA $7.28
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- GNTA 40.06
- FORA 60.82
- Support Level
- GNTA $2.56
- FORA $2.20
- Resistance Level
- GNTA $3.18
- FORA $2.39
- Average True Range (ATR)
- GNTA 0.25
- FORA 0.13
- MACD
- GNTA -0.05
- FORA 0.02
- Stochastic Oscillator
- GNTA 32.93
- FORA 76.47
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.